These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 13678555)

  • 1. Neuroimaging in drug abuse.
    Lindsey KP; Gatley SJ; Volkow ND
    Curr Psychiatry Rep; 2003 Oct; 5(5):355-61. PubMed ID: 13678555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography molecular imaging of dopaminergic system in drug addiction.
    Hou H; Tian M; Zhang H
    Anat Rec (Hoboken); 2012 May; 295(5):722-33. PubMed ID: 22467195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography and single-photon emission computed tomography in substance abuse research.
    Volkow ND; Fowler JS; Wang GJ
    Semin Nucl Med; 2003 Apr; 33(2):114-28. PubMed ID: 12756644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarities and Differences in Neuroimaging.
    Sun YK; Sun Y; Lin X; Lu L; Shi J
    Adv Exp Med Biol; 2017; 1010():73-89. PubMed ID: 29098669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models for addiction medicine: From vulnerable phenotypes to addicted individuals.
    Nader MA
    Prog Brain Res; 2016; 224():3-24. PubMed ID: 26822351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET imaging studies in drug abuse.
    Fowler JS; Volkow ND
    J Toxicol Clin Toxicol; 1998; 36(3):163-74. PubMed ID: 9656971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.
    Howell LL; Murnane KS
    Ann N Y Acad Sci; 2008 Oct; 1141():176-94. PubMed ID: 18991958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET imaging in clinical drug abuse research.
    Gatley SJ; Volkow ND; Wang GJ; Fowler JS; Logan J; Ding YS; Gerasimov M
    Curr Pharm Des; 2005; 11(25):3203-19. PubMed ID: 16250850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging for addiction medicine: From neural mechanisms to clinical considerations.
    Wiers CE; Cabrera E; Skarda E; Volkow ND; Wang GJ
    Prog Brain Res; 2016; 224():175-201. PubMed ID: 26822359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.
    Buchert R; Obrocki J; Thomasius R; Väterlein O; Petersen K; Jenicke L; Bohuslavizki KH; Clausen M
    Nucl Med Commun; 2001 Aug; 22(8):889-97. PubMed ID: 11473208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional studies in substance abuse: imaging and beyond.
    Levin JM; Kaufman MJ
    J Nucl Med; 1995 Jul; 36(7):1298-300. PubMed ID: 7790959
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroimaging and mechanisms of drug abuse: interface of molecular imaging and molecular genetics.
    Ernst M; Kimes AS; Jazbec S
    Neuroimaging Clin N Am; 2003 Nov; 13(4):833-49. PubMed ID: 15024965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward biomarkers of the addicted human brain: Using neuroimaging to predict relapse and sustained abstinence in substance use disorder.
    Moeller SJ; Paulus MP
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt B):143-154. PubMed ID: 28322982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging neurotransmitter release by drugs of abuse.
    Martinez D; Narendran R
    Curr Top Behav Neurosci; 2010; 3():219-45. PubMed ID: 21161755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food addiction: A common neurobiological mechanism with drug abuse.
    Lindgren E; Gray K; Miller G; Tyler R; Wiers CE; Volkow ND; Wang GJ
    Front Biosci (Landmark Ed); 2018 Jan; 23(5):811-836. PubMed ID: 28930574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling human drug abuse and addiction with dedicated small animal positron emission tomography.
    Dalley JW; Fryer TD; Aigbirhio FI; Brichard L; Richards HK; Hong YT; Baron JC; Everitt BJ; Robbins TW
    Neuropharmacology; 2009; 56 Suppl 1():9-17. PubMed ID: 18614184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonhuman primate positron emission tomography neuroimaging in drug abuse research.
    Howell LL; Murnane KS
    J Pharmacol Exp Ther; 2011 May; 337(2):324-34. PubMed ID: 21317354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine addiction: hypothesis derived from imaging studies with PET.
    Volkow ND; Ding YS; Fowler JS; Wang GJ
    J Addict Dis; 1996; 15(4):55-71. PubMed ID: 8943582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron Emission Tomography: Updates on Imaging of Addiction.
    Solingapuram Sai JKK; Hurley RA; Dodda M; Taber KH
    J Neuropsychiatry Clin Neurosci; 2019; 31(4):A6-288. PubMed ID: 31613195
    [No Abstract]   [Full Text] [Related]  

  • 20. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
    Buchert R; Thomasius R; Wilke F; Petersen K; Nebeling B; Obrocki J; Schulze O; Schmidt U; Clausen M
    Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.